Tapewire

Nasdaq · USD

ORIC

Oric Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
4765
SEC CIK
0001796280
Parsed reports
164

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202602
Feb 202601
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202603
Aug 202601
Sep 202602
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 28, 2020 Filed Apr 28, 2020 21:13 UTC
ORBIMED ADVISORS LLCDirector · 10% owner
OrbiMed Capital GP VI LLCDirector · 10% owner
ConversionCommon Stock 1,875,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025990 · doc4.xml · nonDerivative · entry 2

ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner

OrbiMed Capital GP VI LLC · CIK 0001682115 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,156,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

F2 · ownership.nature: This report on Form 4 is jointly filed by Advisors and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, Carl L. Gordon ("Gordon"), a member of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:06 UTC
Chacko JacobDirector · President and CEO
ConversionSeries C Preferred Stock · Derivative 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025981 · doc4.xml · derivative · entry 2

Chacko Jacob · CIK 0001608936 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:06 UTC
Chacko JacobDirector · President and CEO
ConversionCommon Stock 62,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025981 · doc4.xml · nonDerivative · entry 1

Chacko Jacob · CIK 0001608936 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionSeries B Preferred Stock · Derivative 2,268,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 8

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 2,268,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F3 · ownership.nature: The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionSeries D Preferred Stock · Derivative 314,815 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 7

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 314,815 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionSeries C Preferred Stock · Derivative 497,809 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 6

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 497,809 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionSeries B Preferred Stock · Derivative 231,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 5

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 231,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionCommon Stock 2,268,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 4

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,268,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F3 · ownership.nature: The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionCommon Stock 314,815 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 3

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,043,874

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionCommon Stock 497,809 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 2

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 729,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:11 UTC
GUTHART LEO10% owner
ConversionCommon Stock 231,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 1

Topspin Fund L.P. · CIK 0001615782 · 10% owner

Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner

LG Management, LLC · CIK 0001685869 · 10% owner

GUTHART LEO · CIK 0001200183 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionSeries D Preferred Stock · Derivative 151,515 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 8

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 151,515 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionSeries C Preferred Stock · Derivative 416,666 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 7

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 416,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionSeries B Preferred Stock · Derivative 625,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 6

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 625,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionSeries A Preferred Stock · Derivative 3,500,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 5

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,500,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionCommon Stock 151,515 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 4

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,768,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionCommon Stock 416,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 3

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,616,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionCommon Stock 625,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 2

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,200,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:42 UTC
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
ConversionCommon Stock 3,500,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 1

COLUMN GROUP II, LP · CIK 0001600420 · 10% owner

Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner

GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,575,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:07 UTC
GORDON CARL LDirector · 10% owner
ConversionSeries D Preferred Stock · Derivative 236,111 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025983 · doc4.xml · derivative · entry 7

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

Underlying: Common Stock · 236,111 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:07 UTC
GORDON CARL LDirector · 10% owner
ConversionSeries C Preferred Stock · Derivative 373,356 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025983 · doc4.xml · derivative · entry 6

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

Underlying: Common Stock · 373,356 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:07 UTC
GORDON CARL LDirector · 10% owner
ConversionSeries B Preferred Stock · Derivative 1,875,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025983 · doc4.xml · derivative · entry 5

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

Underlying: Common Stock · 1,875,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:07 UTC
GORDON CARL LDirector · 10% owner
ConversionCommon Stock 236,111 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 4

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,765,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:07 UTC
GORDON CARL LDirector · 10% owner
ConversionCommon Stock 373,356 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 3

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,529,606

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:07 UTC
GORDON CARL LDirector · 10% owner
ConversionCommon Stock 1,875,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 2

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 2,156,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:09 UTC ConversionSeries A Preferred Stock · Derivative 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025985 · doc4.xml · derivative · entry 2

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:09 UTC ConversionCommon Stock 25,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025985 · doc4.xml · nonDerivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:08 UTC ConversionSeries A Preferred Stock · Derivative 62,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025984 · doc4.xml · derivative · entry 3

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 62,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 21:08 UTC ConversionCommon Stock 62,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025984 · doc4.xml · nonDerivative · entry 2

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 227,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionSeries D Preferred Stock · Derivative 151,515 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 8

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 151,515 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionSeries C Preferred Stock · Derivative 416,666 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 7

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 416,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionSeries B Preferred Stock · Derivative 625,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 6

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 625,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionSeries A Preferred Stock · Derivative 3,500,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 5

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 3,500,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionCommon Stock 151,515 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 4

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,768,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionCommon Stock 416,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 3

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,616,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionCommon Stock 625,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 2

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,200,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 28, 2020 Filed Apr 28, 2020 17:10 UTC
Svennilson PeterDirector · 10% owner
ConversionCommon Stock 3,500,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 1

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 3,575,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.

F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any.

Read SEC document
April 24, 2020 Filed Apr 28, 2020 21:13 UTC
ORBIMED ADVISORS LLCDirector · 10% owner
OrbiMed Capital GP VI LLCDirector · 10% owner
PurchaseCommon Stock 281,250 $16.00 $4,500,000.00
Disclosure

SEC source: 0001209191-20-025990 · doc4.xml · nonDerivative · entry 1

ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner

OrbiMed Capital GP VI LLC · CIK 0001682115 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 281,250

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

F2 · ownership.nature: This report on Form 4 is jointly filed by Advisors and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, Carl L. Gordon ("Gordon"), a member of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
April 24, 2020 Filed Apr 28, 2020 21:07 UTC
GORDON CARL LDirector · 10% owner
PurchaseCommon Stock 281,250 $16.00 $4,500,000.00
Disclosure

SEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 1

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 281,250

F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:37 UTC
Chacko JacobDirector · President and CEO
GrantStock Option (right to buy) · Derivative 437,500 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025801 · doc4.xml · derivative · entry 1

Chacko Jacob · CIK 0001608936 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 437,500

Underlying: Common Stock · 437,500 shares

Expires 2030-04-22

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:42 UTC
Piscitelli DominicChief Financial Officer
GrantStock Option (right to buy) · Derivative 86,250 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025808 · doc4.xml · derivative · entry 1

Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,250

Underlying: Common Stock · 86,250 shares

Expires 2030-04-22

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:38 UTC
GORDON CARL LDirector · 10% owner
GrantStock Option (right to buy) · Derivative 16,625 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025803 · doc4.xml · derivative · entry 1

GORDON CARL L · CIK 0001282930 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2030-04-22

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) April 23, 2021 or (ii) the business day immediately preceding the Issuer's next annual stockholders' meeting.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:40 UTC GrantStock Option (right to buy) · Derivative 33,250 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025805 · doc4.xml · derivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,250

Underlying: Common Stock · 33,250 shares

Expires 2030-04-22

F1 · derivative.exercise_date: One thirty-sixth (1/36) of the shares subject to the option shall vest May 23, 2020, and an additional thirty-sixth (1/36) of the shares subject to the option shall vest each month thereafter.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:43 UTC
Multani Pratik SChief Medical Officer
GrantStock Option (right to buy) · Derivative 147,500 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025810 · doc4.xml · derivative · entry 1

Multani Pratik S · CIK 0001586894 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,500

Underlying: Common Stock · 147,500 shares

Expires 2030-04-22

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 16:41 UTC
Dier MardiDirector
GrantStock Option (right to buy) · Derivative 33,250 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025807 · doc4.xml · derivative · entry 1

Dier Mardi · CIK 0001574591 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,250

Underlying: Common Stock · 33,250 shares

Expires 2030-04-22

F1 · derivative.exercise_date: One thirty-sixth (1/36) of the shares subject to the option shall vest May 23, 2020, and an additional thirty-sixth (1/36) of the shares subject to the option shall vest each month thereafter.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 20:39 UTC GrantStock Option (right to buy) · Derivative 16,625 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025804 · doc4.xml · derivative · entry 1

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2030-04-22

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) April 23, 2021 or (ii) the business day immediately preceding the Issuer's next annual stockholders' meeting.

Read SEC document
April 23, 2020 Filed Apr 27, 2020 16:41 UTC
Svennilson PeterDirector · 10% owner
GrantStock Option (right to buy) · Derivative 16,625 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001209191-20-025806 · doc4.xml · derivative · entry 1

Svennilson Peter · CIK 0001606074 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,625

Underlying: Common Stock · 16,625 shares

Expires 2030-04-22

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) April 23, 2021 or (ii) the business day immediately preceding the Issuer's next annual stockholders' meeting.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.